1. Home
  2. Analysis
  3. Morphine
  4. Tazverik

Morphine and Tazverik drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Morphine (morphine sulfate) and Tazverik (tazemetostat hydrobromide). Common drug interactions include alopecia among females and infection among males.

The phase IV clinical study analyzes what interactions people have when they take Morphine and Tazverik. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Morphine?

Morphine has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 182,914 Morphine users. Check the latest studies of Morphine.

What is Tazverik?

Tazverik has active ingredients of tazemetostat hydrobromide. eHealthMe is studying from 1,248 Tazverik users. Check the latest studies of Tazverik.

On Aug, 10, 2026

57 people who take Morphine and Tazverik together, and have interactions are studied.

Morphine and Tazverik drug interactions.

What are the common drug interactions of Morphine and Tazverik, by gender? *:

female:

  1. Alopecia (absence of hair from areas of the body)
  2. Constipation
  3. Decreased appetite
  4. Productive cough
  5. Weight decreased
  6. Abdominal pain
  7. Cough
  8. Fatigue (feeling of tiredness)
  9. Nausea (feeling of having an urge to vomit)
  10. Vomiting

male:

  1. Infection
  2. Insomnia (sleeplessness)
  3. Pyrexia (fever)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Neoplasm (tumour)
  6. Vomiting
  7. Disease progression
  8. Death
  9. Diarrhoea
  10. Drug ineffective

What are the common drug interactions of Morphine and Tazverik, by age (0-1 to 60+)? *:

0-1:

  1. Death
  2. Hospitalisation
  3. Pyrexia (fever)
  4. Vomiting

2-9:

n/a

10-19:

  1. Malignant neoplasm progression (cancer tumour came back)
  2. Vomiting

20-29:

n/a

30-39:

  1. Infection
  2. Insomnia (sleeplessness)

40-49:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Neoplasm (tumour)

50-59:

n/a

60+:

  1. Alopecia (absence of hair from areas of the body)
  2. Constipation
  3. Decreased appetite
  4. Productive cough
  5. Weight decreased
  6. Diarrhoea
  7. Disease progression
  8. Drug ineffective
  9. Dysphonia (speech disorder attributable to a disorder of phonation)
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 18 people, 31.58%
  2. Lung Neoplasm Malignant (cancer tumour of lung): 5 people, 8.77%
  3. Epithelioid Sarcoma (cancer of fingers, hands, and forearms): 3 people, 5.26%
  4. Brain Neoplasm Malignant (brain cancer tumour): 3 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Morphine and Tazverik?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Morphine and Tazverik:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Morphine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tazverik:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Morphine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tazverik and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate and tazemetostat hydrobromide (the active ingredients of Morphine and Tazverik, respectively), and Morphine and Tazverik (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.